2018-2023 United States Hydroxycarbamide Market Report

2018-2023 United States Hydroxycarbamide Market Report

Healthcare 25/12/2018 82 List Figures TOC

In 2017, the Hydroxycarbamide market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In United States market, the top players include
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences

Split by product types/category, covering
Capsule
Tablet

Split by applications/end use industries, covers
Sickle Cell Disease
Cancer
Other